Medicines and Poisons (Medicines) Regulation 2021
sch.6-sec.50Dealing authorised
Start here
Get a plain-English read of sch.6-sec.50
Turn the raw legal text into a practical explanation grounded in Medicines and Poisons (Medicines) Regulation 2021.
sch.6-sec.50 Dealing authorised
Column 1 Dealing Column 2 Medicine Column 3 Scope of dealing 1 prescribe clozapine, MDMA or psilocybine a psychostimulant medicine the medicine is prescribed— for the treatment of adult ADHD up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or for the treatment of a relevant child condition 2 give a treatment dose clozapine a psychostimulant medicine the medicine is given— for the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or for the treatment of a relevant child condition 3 dispense clozapine a psychostimulant medicine the medicine is dispensed— for the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or the treatment of a relevant child condition 4 administer clozapine, MDMA or psilocybine a psychostimulant medicine the medicine is administered— for the treatment of adult ADHD, up to an amount that does not exceed the maximum daily dose, if any, for the medicine; or for the treatment of a relevant child condition 5 give a purchase order stock of clozapine, MDMA or psilocybine the stock is not for a specified place stock of a psychostimulant medicine the stock is for the treatment of adult ADHD or relevant child conditions, other than at a specified place 6 possess clozapine, MDMA or psilocybine a psychostimulant medicine the medicine is possessed for a purpose mentioned in this column sch 6 s 50 amd 2023 SL No. 51 s 8 (5) – (6) sub 2025 SL No. 148 s 27 (3)